Quest Historical Balance Sheet
DGX Stock | USD 136.34 1.21 0.88% |
Trend analysis of Quest Diagnostics Incorporated balance sheet accounts such as Other Current Liabilities of 1.6 B or Total Current Liabilities of 1.2 B provides information on Quest Diagnostics' total assets, liabilities, and equity, which is the actual value of Quest Diagnostics to its prevalent stockholders. By breaking down trends over time using Quest Diagnostics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Quest Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Quest Diagnostics is a good buy for the upcoming year.
Quest Diagnostics Inventory |
|
Quest |
About Quest Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Quest Diagnostics at a specified time, usually calculated after every quarter, six months, or one year. Quest Diagnostics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Quest Diagnostics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Quest currently owns. An asset can also be divided into two categories, current and non-current.
Quest Diagnostics Balance Sheet Chart
Quest Diagnostics Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Quest Diagnostics uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Quest Diagnostics' Property Plant Equipment is fairly stable compared to the past year. Total Permanent Equity is likely to rise to about 6 B in 2024, whereas Total Assets are likely to drop slightly above 8.5 B in 2024. Add Fundamental
Total Assets
Total assets refers to the total amount of Quest Diagnostics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Quest Diagnostics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Quest Diagnostics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Quest Diagnostics Incorporated are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Capital Lease Obligations
Quest Diagnostics capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Quest Diagnostics asset purchases. For example, Quest Diagnostics can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Quest Diagnostics control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.Most accounts from Quest Diagnostics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Quest Diagnostics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. At this time, Quest Diagnostics' Property Plant Equipment is fairly stable compared to the past year. Total Permanent Equity is likely to rise to about 6 B in 2024, whereas Total Assets are likely to drop slightly above 8.5 B in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 4.7B | 4.6B | 5.4B | 3.1B | Total Assets | 13.6B | 12.8B | 14.0B | 8.5B |
Quest Diagnostics balance sheet Correlations
Click cells to compare fundamentals
Quest Diagnostics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Quest Diagnostics balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 12.8B | 14.0B | 13.6B | 12.8B | 14.0B | 8.5B | |
Short Long Term Debt Total | 5.3B | 4.7B | 4.7B | 4.6B | 5.4B | 3.1B | |
Other Current Liab | 778M | 1.2B | 1.2B | 1.1B | 1.5B | 1.6B | |
Total Current Liabilities | 2.0B | 1.8B | 1.8B | 1.6B | 1.8B | 1.2B | |
Total Stockholder Equity | 5.6B | 6.8B | 6.4B | 5.9B | 6.3B | 3.9B | |
Property Plant And Equipment Net | 2.0B | 2.2B | 2.3B | 2.4B | 2.4B | 2.5B | |
Net Debt | 4.1B | 3.5B | 3.8B | 4.3B | 4.7B | 2.7B | |
Retained Earnings | 8.2B | 9.3B | 7.6B | 8.3B | 8.8B | 9.3B | |
Accounts Payable | 263M | 446M | 357M | 324M | 1.4B | 1.4B | |
Cash | 1.2B | 1.2B | 872M | 315M | 686M | 720.3M | |
Non Current Assets Total | 10.4B | 11.0B | 10.9B | 10.9B | 11.7B | 6.9B | |
Non Currrent Assets Other | 160M | 176M | 163M | 144M | 198M | 177.5M | |
Cash And Short Term Investments | 1.2B | 1.2B | 872M | 315M | 686M | 720.3M | |
Net Receivables | 1.1B | 1.5B | 1.4B | 1.2B | 1.2B | 892.3M | |
Liabilities And Stockholders Equity | 12.8B | 14.0B | 13.6B | 12.8B | 14.0B | 8.5B | |
Non Current Liabilities Total | 5.1B | 5.4B | 5.3B | 5.3B | 5.8B | 3.3B | |
Inventory | 123M | 223M | 208M | 192M | 190M | 104.0M | |
Other Current Assets | 112M | 157M | 223M | 196M | 286M | 227.8M | |
Other Stockholder Equity | (2.5B) | (2.5B) | (1.2B) | (2.4B) | (2.5B) | (2.4B) | |
Total Liab | 7.1B | 7.1B | 7.0B | 6.8B | 7.6B | 4.6B | |
Property Plant And Equipment Gross | 2.0B | 2.2B | 2.3B | 2.4B | 5.8B | 6.1B | |
Total Current Assets | 2.5B | 3.1B | 2.7B | 1.9B | 2.4B | 1.6B | |
Accumulated Other Comprehensive Income | (59M) | (39M) | (21M) | (14M) | 14M | 14.7M | |
Short Term Debt | 949M | 143M | 153M | 155M | 456M | 241.5M | |
Intangible Assets | 1.2B | 1.1B | 1.2B | 1.1B | 1.2B | 968.0M | |
Other Liab | 683M | 847M | 792M | 812M | 933.8M | 472.6M | |
Other Assets | 64M | 1.3B | 163M | 144M | 165.6M | 196.9M | |
Long Term Debt | 4.0B | 4.0B | 4.0B | 4.0B | 4.4B | 3.0B | |
Property Plant Equipment | 1.5B | 1.6B | 2.3B | 2.4B | 2.7B | 2.8B | |
Good Will | 6.6B | 6.9B | 7.1B | 7.2B | 7.7B | 5.7B | |
Treasury Stock | (5.2B) | (5.4B) | (3.5B) | (4.7B) | (4.2B) | (4.4B) | |
Net Tangible Assets | (1.6B) | (700M) | (1.8B) | (1.9B) | (2.1B) | (2.2B) | |
Noncontrolling Interest In Consolidated Entity | 46M | 50M | 39M | 37M | 42.6M | 34.3M | |
Retained Earnings Total Equity | 8.2B | 9.3B | 7.6B | 8.3B | 9.5B | 6.6B |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Quest Diagnostics information on this page should be used as a complementary analysis to other Quest Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Quest Stock analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Transaction History View history of all your transactions and understand their impact on performance | |
Global Correlations Find global opportunities by holding instruments from different markets |
Is Quest Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quest Diagnostics. If investors know Quest will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quest Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.03) | Dividend Share 2.88 | Earnings Share 7.43 | Revenue Per Share 83.105 | Quarterly Revenue Growth 0.015 |
The market value of Quest Diagnostics is measured differently than its book value, which is the value of Quest that is recorded on the company's balance sheet. Investors also form their own opinion of Quest Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Quest Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quest Diagnostics' market value can be influenced by many factors that don't directly affect Quest Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quest Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quest Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quest Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.